INSM
Insmed IncorporatedPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #759
- Final score
- 37.18
- Years on list
- 1
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- INSM· Insmed Incorporated
- RARE· Ultragenyx Pharmaceutical Inc.
- SHC· Sotera Health Company
Figure 01 · Side-by-side summary
The headline numbers
RARE
Ultragenyx Pharmaceutical Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #720
- Final score
- 40.20
- Years on list
- 4
↗ Climbed 130 since 2022
SHC
Sotera Health CompanyPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #790
- Final score
- 34.32
- Years on list
- 5
↘ Down 307 since 2021
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | INSM | RARE | SHC |
|---|---|---|---|
| Climate Change | 38.9 | 26.8 | 36.6 |
| Employee Relations | 41.6 | 45.1 | 36.1 |
| Environment | 36.2 | 30.1 | 38.1 |
| Stakeholders & Society | 28.2 | 56.9 | 18.3 |
| Human Rights | 37.9 | 50.8 | 44.5 |
| Governance | 34.3 | 38.4 | 23.1 |
| Performance Rating | 44.8 | 51.8 | 46.8 |